Literature DB >> 18521200

Clinical and histopathological prognostic factors in chondrosarcomas.

S Daugaard1, O Myhre-Jensen, T Schiødt, A G Jurik, J Keller, H T Mouridsen, B Lund.   

Abstract

Purpose. In an attempt to identify clinical and histopathological factors of prognostic importance in chondrosarcomas, 115 cases of malignant and borderline chondromatous tumours were reviewed.Patients/methods. Histopathological features tested for prognostic information as well as reproducibility included cellularity, nuclear pleomorphism, multinucleated cells, mitotic activity and grade. Eleven patients had a biopsy only, and a short survival (median 2.0 years); these were excluded from further analysis. The remaining 104 patients who had received intended curative treatment had a median survival of 14.7 years.Results. In univariate analysis, tumour size, extra-compartmental growth, surgical margin and sex were significantly correlated to recurrence-free survival (RFS); sex was marginally significant while age, site and pathological parameters were not significant. Overall survival (OAS) was likewise found to be independent of pathological features as well as site, size and surgical margin; but age, sex and extra-compartmental growth were statistically significant. However, when the same parameters were entered into a stepwise Cox (multivariate) analysis, only surgical margin, cellularity and pleomorphism were significantly related to RFS; margin, grade, pleomorphism and age to OAS. Overall inter-observer agreement on grade was relatively low: 0.54, with a Kappa value of 0.32. It was not better for the other histological parameters, with the exception of the mitotic count. However, acceptable values were achieved when the material was divided into low-grade (grade I and below) vs high-grade (grade II and III) lesions: overall agreement 0.79, Kappa 0.56.Discussion. Although the grading of chondrosarcomas is in need of improvement, its replacement by semiquantitative evaluation of individual histopathological parameters as performed in this study offers no advantage. Among the clinical parameters, only the adequacy of the surgical treatment and the patient's age appear to be important.

Entities:  

Year:  1997        PMID: 18521200      PMCID: PMC2373582          DOI: 10.1080/13577149778470

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  23 in total

1.  Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic.

Authors:  H Svanholm; H Starklint; H J Gundersen; J Fabricius; H Barlebo; S Olsen
Journal:  APMIS       Date:  1989-08       Impact factor: 3.205

Review 2.  Chondrosarcoma and other rare bone sarcomas.

Authors:  A T Van Oosterom; L Y Dirix
Journal:  Curr Opin Oncol       Date:  1990-06       Impact factor: 3.645

3.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

4.  Silver-stained nucleolar organizer proteins in chondrosarcoma.

Authors:  T Ohno; T Tanaka; S Takeuchi; T Matsunaga; H Mori
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1991

5.  Cytophotometric DNA measurements of chondrosarcoma: methodologic aspects of measurements in tissue sections from old paraffin-embedded specimens.

Authors:  A Kreicbergs; A Zetterberg
Journal:  Anal Quant Cytol       Date:  1980-06

6.  Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features.

Authors:  A Kreicbergs; L Boquist; B Borssén; S E Larsson
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

7.  Chondrosarcomas of the head and neck.

Authors:  D S Ruark; U K Schlehaider; J P Shah
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

8.  Histological grading and morphometric analysis of cartilaginous tumours.

Authors:  T Ishida; F Kikuchi; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

9.  A morphometric approach to the grading of chondroid tumours on fine-needle smears.

Authors:  P Zeppa; A Zabatta; G Marino; R Boschi; G di Benedetto; F Fazioli; A Vetrani; G De Rosa; L Palombini
Journal:  Pathol Res Pract       Date:  1989-11       Impact factor: 3.250

10.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.

Authors:  J M Coindre; M Trojani; G Contesso; M David; J Rouesse; N B Bui; A Bodaert; I De Mascarel; A De Mascarel; J F Goussot
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

View more
  3 in total

1.  Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.

Authors:  Søren Daugaard; Lise H Christensen; Estrid Høgdall
Journal:  APMIS       Date:  2009-07       Impact factor: 3.205

2.  Clinicopathologic correlation of chondrosarcoma of mandible with a case report.

Authors:  Sanchita Kundu; Mousumi Pal; Ranjan R Paul
Journal:  Contemp Clin Dent       Date:  2011-10

3.  Chondrosarcoma: the impact of comorbidity - 30 years of experience from a population-based database including 199 consecutive chondrosarcoma patients.

Authors:  Ninna Aggerholm-Pedersen; Katja Maretty-Nielsen; Steen Baerentzen; Peter Holmberg Jørgensen; Bjarne Hauge Hansen; Thomas Baad-Hansen; Johnny Keller; Akmal Safwat
Journal:  Orthop Res Rev       Date:  2019-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.